Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Moller-Tank

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Virology|June 8, 2018
TIM-1 Mediates Dystroglycan-Independent Entry of Lassa VirusRachel B Brouillette, Elisabeth K Phillips, Radhika Patel, et al.
Nature Protocols|September 21, 2023
Structure-guided AAV capsid evolution strategies for enhanced CNS gene deliveryTrevor J Gonzalez, Aaron Mitchell-Dick, Leo O Blondel, et al.
Journal of Virology|July 31, 2024
Sub-genomic flaviviral RNA elements increase the stability and abundance of recombinant AAV vector transcriptsRita M Meganck, Roza Ogurlu, Jiacheng Liu, et al.
Mbio|September 7, 2017
TIM1 (HAVCR1) Is Not Essential for Cellular Entry of Either Quasi-enveloped or Naked Hepatitis A VirionsAnshuman Das, Asuka Hirai-Yuki, Olga González-López, et al.
Scientific Reports|August 18, 2022
Efficient engraftment and viral transduction of human hepatocytes in an FRG rat liver humanization modelMarisa Carbonaro, Jeffrey Lee, Evangelos Pefanis, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 4, 2011
T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria MarburgvirusAndrew S Kondratowicz, Nicholas J Lennemann, Patrick L Sinn, et al.
Science Advances|April 14, 2023
IL-6-GP130 signaling protects human hepatocytes against lipid droplet accumulation in humanized liver modelsMarisa Carbonaro, Kehui Wang, Hui Huang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 17, 2021
Cell type-selective targeted delivery of a recombinant lysosomal enzyme for enzyme therapiesAndrew D Baik, Philip Calafati, Xiaoli Zhang, et al.
Nature Communications|May 14, 2021
Tissue-specific activation of gene expression by the Synergistic Activation Mediator (SAM) CRISPRa system in miceCharleen Hunt, Suzanne A Hartford, Derek White, et al.
Nature Communications|December 17, 2017
Hepatocytic expression of human sodium-taurocholate cotransporting polypeptide enables hepatitis B virus infection of macaquesBenjamin J Burwitz, Jochen M Wettengel, Martin A Mück-Häusl, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Virology|June 8, 2018
TIM-1 Mediates Dystroglycan-Independent Entry of Lassa VirusRachel B Brouillette, Elisabeth K Phillips, Radhika Patel, et al.
Nature Protocols|September 21, 2023
Structure-guided AAV capsid evolution strategies for enhanced CNS gene deliveryTrevor J Gonzalez, Aaron Mitchell-Dick, Leo O Blondel, et al.
Journal of Virology|July 31, 2024
Sub-genomic flaviviral RNA elements increase the stability and abundance of recombinant AAV vector transcriptsRita M Meganck, Roza Ogurlu, Jiacheng Liu, et al.
Mbio|September 7, 2017
TIM1 (HAVCR1) Is Not Essential for Cellular Entry of Either Quasi-enveloped or Naked Hepatitis A VirionsAnshuman Das, Asuka Hirai-Yuki, Olga González-López, et al.
Scientific Reports|August 18, 2022
Efficient engraftment and viral transduction of human hepatocytes in an FRG rat liver humanization modelMarisa Carbonaro, Jeffrey Lee, Evangelos Pefanis, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 4, 2011
T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria MarburgvirusAndrew S Kondratowicz, Nicholas J Lennemann, Patrick L Sinn, et al.
Science Advances|April 14, 2023
IL-6-GP130 signaling protects human hepatocytes against lipid droplet accumulation in humanized liver modelsMarisa Carbonaro, Kehui Wang, Hui Huang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 17, 2021
Cell type-selective targeted delivery of a recombinant lysosomal enzyme for enzyme therapiesAndrew D Baik, Philip Calafati, Xiaoli Zhang, et al.
Nature Communications|May 14, 2021
Tissue-specific activation of gene expression by the Synergistic Activation Mediator (SAM) CRISPRa system in miceCharleen Hunt, Suzanne A Hartford, Derek White, et al.
Nature Communications|December 17, 2017
Hepatocytic expression of human sodium-taurocholate cotransporting polypeptide enables hepatitis B virus infection of macaquesBenjamin J Burwitz, Jochen M Wettengel, Martin A Mück-Häusl, et al.
Pageof 2